Clinical and Microbiological Characteristics of Intestinal Microbiocenosis Disorders In HIV-Positive Children with Acute Diarrhea
DOI registered with Crossref
https://doi.org/10.37547/ijmsphr/Volume07Issue02-13
Keywords
HIV infection
children
acute infectious diarrhea
Abstract
Acute infectious diarrhea (AID) is a frequent and serious complication in children living with HIV. This study aims to investigate the composition and severity of intestinal microbiota disruption (dysbiosis) in HIV-positive children with AID compared to HIV-negative peers. A total of 499 children aged 7–18 years were included. Dysbiosis was classified into four stages, and correlations with clinical parameters, immunodeficiency levels, and viral loads were assessed. Our results show that advanced dysbiosis (stages III–IV) is significantly more prevalent in HIV-infected children, particularly those with high viral loads and severe immunodeficiency. Early detection and correction of dysbiosis are essential to prevent further complications and support immune recovery.
Downloads
Download data is not yet available.
References
1
Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365–1371.
2
Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258–1270.
3
Clerici M, Shearer GM. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993;14(2):107–111.
4
Dillon SM, Lee EJ, Kotter CV, et al. An altered intestinal mucosal microbiome in HIV 1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 2014;7(5):983–994.
5
Dillon SM, Lee EJ, Guo K, et al. HIV infection of the gastrointestinal tract: consequences for mucosal immunity and the microbiota. Curr Opin HIV AIDS. 2016;11(2):111–119.
6
Elbireer AM, et al. Intestinal infections and dysbiosis in HIV infected patients: mechanisms and therapeutic strategies. J Infect Dis. 2015;212(Suppl 2):S132–S140.
7
Gordon JI, Li H, et al. Influence of HIV infection on gut microbiota and mucosal immune function. Annu Rev Immunol. 2015;33:619–645.
8
Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361(9356):512–519.
9
Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol. 2013;21(1):6–13.
10
Lloyd Price J, Abu Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51.
11
Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev. 2013;26(1):2–18.
12
Montecino Rodriguez E, Berney K, Dorshkind K. Impact of infectious diarrhea on gut microbiota in HIV infected children. Clin Infect Dis. 2018;66(3):428–435.
13
Mutlu EA, et al. HIV infection is associated with compositional and functional changes in the gut microbiota. PLoS Pathog. 2014;10(3):e1004409.
14
Navarro González I, RamÃrez Tenorio A, MartÃnez Costa C, et al. Effect of a nutritional intervention on the intestinal microbiota of vertically HIV infected children: the Pediabiota study. Nutrients. 2020;12(7):2112.
15
Nowak P, Troseid M, Avershina E, et al. Gut microbiota diversity predicts immune status in HIV 1 infection. AIDS. 2015;29(18):2409–2418.
16
Petrova MI, et al. Lactobacillus species as biomarkers and modulators of gut health in HIV infection. Front Microbiol. 2017;8:1510.
17
Sandler NG, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780–791.
18
Schuijt TJ, Lankelma JM, Scicluna BP, et al. The gut microbiota plays a protective role in the host defense against pneumococcal pneumonia. Gut. 2016;65(4):575–583.
19
Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339(6119):548–554.
20
Tamburini FB, Andermann TM, Tkachenko E, et al. Precision identification of diverse bloodstream pathogens in the gut microbiome. Nature. 2018;558(7708):112–116.
21
Terruzzi V, Bischoff S, Roda G, et al. Gut microbiota role in HIV pathogenesis and treatment: are they friend or foe? Int J Mol Sci. 2021;22(11):5473.
22
Vujkovic Cvijin I, Dunham RM, Iwai S, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5(193):193ra91.
23
Vujkovic Cvijin I, Somsouk M. HIV and the gut microbiota: composition, consequences, and avenues for amelioration. Curr HIV/AIDS Rep. 2019;16(3):204–213.
24
Walker AW, et al. HIV infection and the gut microbiome: implications for therapy. Curr Opin HIV AIDS. 2017;12(3):201–208.
25
Witkowski M, et al. Dysbiosis, microbial translocation, and immune dysfunction in HIV infection: pathophysiological pathways and clinical implications. Front Immunol. 2021;12:638114.
26
WHO. WHO Guidelines for the treatment of HIV infection in children. Geneva: World Health Organization; 2021.
27
Zhou Y, et al. Gut microbiota and immune responses in pediatric HIV infection: clinical implications. Pediatr Res. 2019;85(4):493–500.
28
Zhang L, et al. Microbiota and immune system interplay in pediatric HIV infection. Front Immunol. 2018;9:1234.